Literature DB >> 11069740

Magnetic resonance imaging in the management of suspected spinal canal disease in patients with known malignancy.

G J Loughrey1, C D Collins, S M Todd, N M Brown, R J Johnson.   

Abstract

AIM: The aim of this study was to examine the spectrum of spinal canal disease in patients with known malignancy using magnetic resonance imaging (MRI).
MATERIALS AND METHODS: One hundred and fifty-five patients underwent a total of 159 spinal MRI examinations over a three-year period. Patients were examined using a 1.0T magnet and a phased array surface spine coil. Sagittal T1 weighted spin echo and STIR sequences were routinely employed. Axial T1 and T2 weighted spin echo images were obtained at sites of identified pathology. Contrast enhanced sagittal and axial T1 weighted spin echo images were acquired when the unenhanced appearances did not correlate with the clinical findings or when the images suggested intradural or intramedullary disease.
RESULTS: Malignant disease affecting the spinal cord or cauda equina was noted in 104/159 (65%) patients (extradural n= 78, intradural n= 20, intramedullary n= 7); one patient had evidence of both intradural and intramedullary deposits. Multiple levels of extradural cord/cauda equina compression were present in 18/78 patients (23%). The thoracic spine was the most frequently affected (74%). Bone elements were the major component of extradural compression in 11/78 patients (14%). Intradural metastases were multiple in 15/20 patients (75%). Four of the six solitary intramedullary metastases were situated in the conus medullaris.
CONCLUSION: Magnetic resonance imaging of the entire spine is the investigation of choice in patients with known malignancy and suspected spinal canal disease. Contrast-enhanced images should be acquired when the unenhanced appearances do not correlate with the clinical findings or when they suggest intradural or intramedullary disease.Loughrey, G. J. (2000). Clinical Radiology55, 849-855. Copyright 2000 The Royal College of Radiologists.

Entities:  

Mesh:

Year:  2000        PMID: 11069740     DOI: 10.1053/crad.2000.0547

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  11 in total

1.  Multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2004-01-14       Impact factor: 3.909

2.  Modern approaches to the management of metastatic epidural spinal cord compression.

Authors:  Zain A Husain; Arjun Sahgal; Eric L Chang; Pejman Jabehdar Maralani; Charlotte D Kubicky; Kristin J Redmond; Charles Fisher; Ilya Laufer; Simon S Lo
Journal:  CNS Oncol       Date:  2017-07-18

3.  Surgical treatment of intramedullary spinal cord metastases of systemic cancer: functional outcome and prognosis.

Authors:  T Gasser; I E Sandalcioglu; B El Hamalawi; J A P van de Nes; D Stolke; H Wiedemayer
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

Review 4.  Multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2010-02-11       Impact factor: 3.909

5.  [Solitary spinal metastases. Is aggressive surgical management justified?].

Authors:  C Druschel; A C Disch; M Pumberger; P Schwabe; I Melcher; N P Haas; K-D Schaser
Journal:  Orthopade       Date:  2013-09       Impact factor: 1.087

6.  A case of indirect cauda equina syndrome from metastatic prostate cancer.

Authors:  Shilo Lefresne; Alysa Fairchild; Aalo Bistritz; Peter Venner; Don Yee
Journal:  Can Urol Assoc J       Date:  2009-08       Impact factor: 1.862

7.  Problems monitoring response in multiple myeloma.

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2005-11-23       Impact factor: 3.909

8.  Malignant spinal cord compression: a retrospective audit of clinical practice at a UK regional cancer centre.

Authors:  A McLinton; C Hutchison
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

9.  [Clinical Features of Intradural Extramedullary Spinal Cord Metastases 
in Primary Lung Cancer].

Authors:  Yan Xu; Wei Zhong; Jing Zhao; Minjiang Chen; Longyun Li; Mengzhao Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-08-20

10.  ALK-rearranged lung cancer with intradural extramedullary spinal cord metastases responding to ceritinib treatment: A case report.

Authors:  Yan Xu; Wei Zhong; Minjiang Chen; Jing Zhao; Mengzhao Wang
Journal:  Thorac Cancer       Date:  2018-06-04       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.